From Labs to Labels: ASU’s Cutting-Edge Medical Devices Win Global Recognition and FDA Approval
ASU is a university on the forefront of biomedical ingenuity, even without a traditional in-house medical school. ASU-linked medical inventions and patents routinely garner international renown, major donor funding and – eventually – FDA approval for clinical application.
Along with its wealth of creative and dedicated students and faculty, ASU owes the success of these biomedical enterprises partly to numerous research partnerships with renowned institutions across the nation, coupled with a diverse array of interdisciplinary research institutions like the Biodesign Institute, which uses natural ecological systems to create sustainable solutions that address healthcare’s most complex global challenges.
Cloud-Based Computational Modeling Platform Illustrates Surgical Outcomes
Backed by Skysong’s $20,000 in seed funding, coaching team and commercialization resources, EndoVantage nabbed a further $250,000 from the Arizona Commerce Authority the following year.
A Brighter Outlook for Jaundice with NeoLight
NeoLight’s New Horizons
Enter Kopparthi’s devices, which are lightweight, utilize solar power and LED lighting and are ergonomically friendly for infants as well as hospital staff. Importantly, these systems can also be placed directly next to the mother’s bedside, which helps to facilitate critical maternal bonding during the first days of life. And while the NeoLight can be set according to an automated timer, its smaller counterpart, the NeoLight Freedom, only requires one switch, reducing costs and improving ease of use—making it perfect for less industrialized nations. Both devices require only five watts of energy and can run for more than 20,000 hours.
Skysong Innovations was introduced to NeoLight when Kopparthi’s team pitched a prototype at ASU’s Edson Student Entrepreneur Initiative. Recognizing the revolutionary national and global potential of the student-developed device, Skysong Innovations vested Kopparthi and his team with a $20,000 grant, office space, input from a personal venture manager and consistent feedback from a customized scientific and entrepreneurial mentor network. Skysong Innovations also communicated with ASU professors and staff so that Kopparthi’s team could continue taking classes while they worked to get NeoLight international recognition—and with it, FDA clearance.
And while this level of involvement may sound exceptional, it’s standard for all of the entrepreneurial teams born at ASU and housed at Skysong.
ASU consistently outperforms the competition across a number of institutional ranking surveys. In 2016, the National Academy of Inventors and IP Owners Association ranked ASU 30th in a survey of U.S. patents issued to universities around the globe. And the Milken Institute placed ASU 6th in its list of best universities for tech transfer among those without a medical school—21st overall.
The above are only a handful of over 144 success stories that Skysong has been privileged to sponsor and support. Drawing from Skysong’s continued encouragement and entrepreneurial expertise, these innovations, patents and corporations are raising the bar at ASU—and revolutionizing science and medicine around the globe.